KEYNOTE-010: flash of a supernova (immune-checkpoint inhibitors) in second-line non-small cell lung cancer

被引：2
作者：
Horinouchi, Hidehito [1 ]
机构：
[1] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, 5-1-1,Tsukiji, Tokyo 1040045, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2017年 / 9卷 / 11期
关键词：
OPEN-LABEL; DOCETAXEL; PEMBROLIZUMAB; NIVOLUMAB;
D O I：
10.21037/jtd.2017.10.135
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：4187 / 4190
页数：4
相关论文
共 7 条
  • [1] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639
  • [2] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
    Brahmer, Julie
    Reckamp, Karen L.
    Baas, Paul
    Crino, Lucio
    Eberhardt, Wilfried E. E.
    Poddubskaya, Elena
    Antonia, Scott
    Pluzanski, Adam
    Vokes, Everett E.
    Holgado, Esther
    Waterhouse, David
    Ready, Neal
    Gainor, Justin
    Aren Frontera, Osvaldo
    Havel, Libor
    Steins, Martin
    Garassino, Marina C.
    Aerts, Joachim G.
    Domine, Manuel
    Paz-Ares, Luis
    Reck, Martin
    Baudelet, Christine
    Harbison, Christopher T.
    Lestini, Brian
    Spigel, David R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135
  • [3] Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
    Garon, Edward B.
    Ciuleanu, Tudor-Eliade
    Arrieta, Oscar
    Prabhash, Kumar
    Syrigos, Konstantinos N.
    Goksel, Tuncay
    Park, Keunchil
    Gorbunova, Vera
    Dario Kowalyszyn, Ruben
    Pikiel, Joanna
    Czyzewicz, Grzegorz
    Orlov, Sergey V.
    Lewanski, Conrad R.
    Thomas, Michael
    Bidoli, Paolo
    Dakhil, Shaker
    Gans, Steven
    Kim, Joo-Hang
    Grigorescu, Alexandru
    Karaseva, Nina
    Reck, Martin
    Cappuzzo, Federico
    Alexandris, Ekaterine
    Sashegyi, Andreas
    Yurasov, Sergey
    Perol, Maurice
    [J]. LANCET, 2014, 384 (9944) : 665 - 673
  • [4] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
    Herbst, Roy S.
    Baas, Paul
    Kim, Dong-Wan
    Felip, Enriqueta
    Perez-Gracia, Jose L.
    Han, Ji-Youn
    Molina, Julian
    Kim, Joo-Hang
    Arvis, Catherine Dubos
    Ahn, Myung-Ju
    Majem, Margarita
    Fidler, Mary J.
    de Castro, Gilberto, Jr.
    Garrido, Marcelo
    Lubiniecki, Gregory M.
    Shentu, Yue
    Im, Ellie
    Dolled-Filhart, Marisa
    Garon, Edward B.
    [J]. LANCET, 2016, 387 (10027) : 1540 - 1550
  • [5] Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
    Langer, Corey J.
    Gadgeel, Shirish M.
    Borghaei, Hossein
    Papadimitrakopoulou, Vassiliki A.
    Patnaik, Amita
    Powell, Steven F.
    Gentzler, Ryan D.
    Martins, Renato G.
    Stevenson, James P.
    Jalal, Shadia I.
    Panwalkar, Amit
    Yang, James Chih-Hsin
    Gubens, Matthew
    Sequist, Lecia V.
    Awad, Mark M.
    Fiore, Joseph
    Ge, Yang
    Raftopoulos, Harry
    Gandhi, Leena
    [J]. LANCET ONCOLOGY, 2016, 17 (11) : 1497 - 1508
  • [6] Lindauer A, 2017, CPT-PHARMACOMET SYST, V6, P11, DOI 10.1002/psp4.12130
  • [7] Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
    Rittmeyer, Achim
    Barlesi, Fabrice
    Waterkamp, Daniel
    Park, Keunchil
    Ciardiello, Fortunato
    von Pawel, Joachim
    Gadgeel, Shirish M.
    Hida, Toyoaki
    Kowalski, Dariusz M.
    Dols, Manuel Cobo
    Cortinovis, Diego L.
    Leach, Joseph
    Polikoff, Jonathan
    Barrios, Carlos
    Kabbinavar, Fairooz
    Frontera, Osvaldo Aren
    De Marinis, Filippo
    Turna, Hande
    Lee, Jong-Seok
    Ballinger, Marcus
    Kowanetz, Marcin
    He, Pei
    Chen, Daniel S.
    Sandler, Alan
    Gandara, David R.
    [J]. LANCET, 2017, 389 (10066) : 255 - 265
1